Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
01/2003
01/29/2003EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
01/29/2003EP0906294B1 Benzoxazinone dopamine d4 receptor antagonists
01/29/2003EP0708769B1 Substituted 2-fused phenylpyridines with herbicidal activity
01/29/2003CN1100055C Piperazine and piperidine compounds
01/23/2003WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
01/21/2003US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity
01/21/2003US6509337 A method of treating a mammalian disease condition mediated by metalloproteinase activity which comprises administering to a mammal in need thereof a therapeutically effective amount of a compound as defined in claim 1 or a pharmaceutically
01/21/2003US6509335 This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of
01/21/2003US6509334 Cyclocarbamate derivatives as progesterone receptor modulators
01/21/2003US6509309 Cleaning composition comprising alkoxy substituted perfluoro compounds
01/16/2003US20030013707 Enzyme inhibitor
01/15/2003EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
01/15/2003EP0925287B1 Heterocyclic metalloprotease inhibitors
01/15/2003EP0790988B1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
01/15/2003CN1391473A VLA-4 inhibitor compounds
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/14/2003US6506894 Solution phase synthesis of oligonucleotides
01/14/2003US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
01/14/2003US6506459 Coating compositions containing alkoxy substituted perfluoro compounds
01/09/2003WO2003002514A1 3-aryl-alpha-amino propanoic acid derivatives and a process for their preparation
01/09/2003WO2002069994A3 Combined use of derivatives of glp-1 analogs and ppar ligands
01/09/2003US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives
01/08/2003EP1272175A2 Il-8 receptor antagonists
01/07/2003US6504066 Reduction of halogen containing carbocyclic ketones, to form chemical intermediates which are substance-P receptor antagonists useful as antiinflammatory and antiemetic agents and for treatment of psychological disorders
01/07/2003US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
01/03/2003WO2003000323A1 Safety shield system for prefilled syringes
01/03/2003WO2003000322A1 Safety shield system for prefilled syringes
01/03/2003WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/03/2003CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/02/2003US20030004341 Antidiabetic agents and dietetics
01/02/2003US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents
12/2002
12/31/2002US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases
12/31/2002US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/27/2002WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
12/24/2002US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002US6498154 Cyclic regimens using quinazolinone and benzoxazine derivatives
12/24/2002US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/19/2002WO2002100843A1 Phenoxazine compounds, the compositions containing them and their medicinal uses
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002US20020193291 Treating NIDDM with RXR agonists
12/18/2002EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002EP1265844A1 Method for producing amines by the hydroaminomethylation of olefins in the presence of ionic liquids
12/18/2002EP1265606A1 Cell adhesion inhibitors
12/18/2002EP0869949B1 Benzoxazine antimicrobial agents
12/18/2002EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002CN1385425A Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1,4-dihydro-2H-3,1-benzoxazine-2-ketone
12/18/2002CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002CA2204616C Ppar gamma antagonists for treating obesity
12/17/2002CA2064783C Cytoprotective fatty moiety compounds
12/12/2002WO2002098424A1 Novel anti-infectives
12/12/2002US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002CA2449770A1 Novel anti-infectives
12/10/2002US6492515 For therapy of hiv infection
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/05/2002WO2002096872A1 Substituted imidates as pesticidal agents
12/05/2002WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002WO2002048123A3 Process for the preparation of morpholinones
12/05/2002US20020183518 Use for treatment of human and animal disorders, for purification of proteins or glycoproteins, and in diagnosis
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002DE10125963A1 Substituierte Imidate Substituted Imidates
12/05/2002CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/04/2002EP1261329A2 Il-8 receptor antagonists
12/03/2002CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
11/2002
11/28/2002WO2002094797A1 Oxazin(thi)one compounds used as fungicides
11/28/2002WO2002020002A3 A method for treating allergies
11/28/2002CA2446141A1 Oxazin(thi)one compounds used as fungicides
11/27/2002EP1259551A1 Polymerization compositions and methods
11/27/2002EP1259496A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/26/2002CA2262502C 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
11/26/2002CA2246482C Novel trans-3,4,4a,5,6,10b-hexahydro-2h-naphth¢1,2-b!-1,4-oxazines disubstitutes, process for preparing them and pharmaceutical compounds containing them
11/21/2002WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
11/21/2002WO2002028841B1 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/21/2002US20020173647 Polymorphic/pseudopolymorphic forms of arginine salt of 3-(4-(2-(phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acid
11/21/2002US20020173529 Fungicide active substance combinations
11/21/2002DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/19/2002US6482946 High char yield benzoxazine compositions
11/19/2002US6482824 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002US20020169146 Pharmaceutically acceptable salts of tricyclic compounds
11/14/2002US20020169098 Cleaning composition
11/13/2002EP1255743A1 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
11/13/2002EP1255742A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
11/13/2002EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002CN1379779A Process for preparation of benzoxazine derivatives and intermediates therefor
11/12/2002US6479662 Antitumor dibenzofluorene derivatives
11/12/2002US6479608 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 112